Targeted Medical Pharma Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
Provider: Wright Reports
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Targeted Medical Pharma Inc Announces Initial Results from a Clinical Observation of Medical Foods for Autistic Spectrum Disorder Symptoms
Targeted Medical Pharma Inc announced preliminary findings from an investigator initiated clinical observation of amino acid based medical foods to address specific nutrient deficiencies in children with autism spectrum disease (ASD) symptoms. 26 children ages seven to sixteen were treated for a time period ranging between 30 days and 1 year, who were diagnosed with ASD or suffering from related symptoms including explosive behavior, social isolation, and mood disorder. The investigator reported that children demonstrated significant improvement with regards to decreased disruptive outbursts, improved socialization, improved mood and reduction in drug dose. 100% of patients have responded positively with an average improvement in explosive outbursts at 83% compared to baseline, with patients also demonstrating significant improvements in anxiety and mood regulation.
Latest Developments for Targeted Medical Pharma Inc
- Targeted Medical Pharma Inc Announces Change Of Auditors
- Targeted Medical Pharma Inc Appoints Dr. David Silver As President
- Targeted Medical Pharma Inc Announces Appointment Of President-Form 8-K
- Clinical Trials Show Targeted Medical Pharma Inc's Theramine Is Effective At Reducing Inflammation Associated With Chronic Back Pain
- Share this
- Digg this